Notch in ovarian cancer

Emily Gerry, Vivek Singh, Tian Li Wang

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Ovarian cancers are malignancies for which improved therapeutic approaches are urgently needed. The development of chemoresistance in ovarian high-grade serous carcinoma is almost inevitable, and researchers are constantly seeking new pathways to target in order to improve the dismal survival rates of women diagnosed with this disease. The Notch pathway in ovarian cancer represents a promising subject for research into new ovarian cancer treatment modalities. Over the last 12 years, the major Notch proteins (Notch1 and NOTCH3), prominent Notch ligands (JAG1 and DLL4), and downstream proteins (Hes1 and DLGAP5) have begun to be studied in ovarian cancers. The roles of Notch in conferring chemoresistance and acting in angiogenesis have also been demonstrated. Additionally, GSI and DLL4 inhibitors as well as Notch antibodies continue to be explored in both clinical and nonclinical settings. It is clear that future studies are needed in order to translate the results from these preclinical studies into practice. Most importantly, it is crucial to demonstrate the safety and efficacy of Notchbased therapy in ovarian cancer patients. There is still much work to be done in examining the pathways and proteins with which Notch may be associated as well as in developing more specific and more effective means of inhibiting Notch pathway components.

Original languageEnglish (US)
Title of host publicationTargeting Notch in Cancer
Subtitle of host publicationFrom the Fruit Fly to the Clinic
PublisherSpringer New York
Pages153-173
Number of pages21
ISBN (Electronic)9781493988594
ISBN (Print)9781493988570
DOIs
StatePublished - Nov 23 2018

Keywords

  • Cancer stem cells
  • Chemoresistance
  • Notch
  • Ovarian cancer
  • Platinum resistance

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Notch in ovarian cancer'. Together they form a unique fingerprint.

  • Cite this

    Gerry, E., Singh, V., & Wang, T. L. (2018). Notch in ovarian cancer. In Targeting Notch in Cancer: From the Fruit Fly to the Clinic (pp. 153-173). Springer New York. https://doi.org/10.1007/978-1-4939-8859-4_6